APA (7th ed.) Citation

Jiang, X., Zhu, X., Xu, H., Zhao, Z., Li, S., Li, S., . . . Cao, J. (2017). Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/ JNK and potentiates cisplatin efficacy in gastric cancer treatment. Acta pharmacologica Sinica, 38(7), 1048-1058. https://doi.org/10.1038/aps.2016.176

Chicago Style (17th ed.) Citation

Jiang, Xiao-yan, Xiao-song Zhu, Hong-ya Xu, Zhong-xi Zhao, Si-ying Li, Shan-zhong Li, Jian-hua Cai, and Ji-min Cao. "Diallyl Trisulfide Suppresses Tumor Growth Through the Attenuation of Nrf2/Akt and Activation of P38/ JNK and Potentiates Cisplatin Efficacy in Gastric Cancer Treatment." Acta Pharmacologica Sinica 38, no. 7 (2017): 1048-1058. https://doi.org/10.1038/aps.2016.176.

MLA (9th ed.) Citation

Jiang, Xiao-yan, et al. "Diallyl Trisulfide Suppresses Tumor Growth Through the Attenuation of Nrf2/Akt and Activation of P38/ JNK and Potentiates Cisplatin Efficacy in Gastric Cancer Treatment." Acta Pharmacologica Sinica, vol. 38, no. 7, 2017, pp. 1048-1058, https://doi.org/10.1038/aps.2016.176.